Attached files
| file | filename |
|---|---|
| EX-99.1 - CANNAPHARMARX, INC. | ex99.1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): January 11, 2016
CANNAPHARMARX, Inc.
(Exact name of Registrant as specified in its charter)
|
Delaware |
000-27055 |
24-4635140 |
|
(State or Other Jurisdiction of Incorporation or Organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
0056 Edwards Village Blvd., Suite 124
PO Box 3000, PMB 106
Edwards, CO 81632
(Address of Principal Executive Offices)
856-376-0500
(Registrant's Telephone Number, Including Area Code)
PO Box 5035, Edwards, CO 81632
________________________________________
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On January 11, 2016, Wendy DiCicco resigned as a Director of the Company. Her resignation was accepted at the time by then-Interim President Jim Smeeding. A copy of Ms. DiCicco's resignation is attached to this Report as Exhibit 99.1.
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statements and Exhibits
(d) Exhibits. The following is a complete list of exhibits filed as part of this Report. Exhibit numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.
|
Exhibit No. |
Description |
|
99.1 |
Resignation of Wendy DiCicco |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CannaPharmaRx, Inc.
By:
____/s/ Gary Herick_________________
Gary Herick
Title: Acting CEO
Date: June 1, 2016